This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
Ex vivo
In vitro
In vivo
By sample type
Bone marrow stromal cells
Breast cancer cell (MCF7)
Breast cancer cells (4T1)
Breast cancer cells (MCF7)
Breast cancer cells (MDA-MB-231)
Colorectal cancer cell (SW480)
Colorectal cancer cell (SW620)
Leukemia cell (K562)
Lung cancer cell (DMS563)
Lung cancer cell (NCI_H69)
Lung cancer cell (SBC-3)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Metastatic gastric cacncer cell (AZP7a)
Metastatic gastric cancer cell (AZ521)
Multiple myeloma cells (KMS-11)
Multiple myeloma cells (RPMI8226)
Multiple myeloma cells (U266)
Plasma
By sample status
24 hr culture
72 hr culture
Hypoxic condition (24 hr)
Multiple myeloma patients
Normal
Normal_old
Survived under long-term hypoxia
Type 1 diabetes
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-216a-5p
MIMAT0000273
0.0e+0
3.3e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
1.3e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
0.0e+0
3.9e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
5.0e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
3.1e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
0.0e+0
3.8e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
1.6e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
0.0e+0
4.8e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
3.2e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
2.0e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
0.0e+0
4.5e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
3.8e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
2.2e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
4.5e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
1.8e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
4.3e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
1.6e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
1.3e-7
0.0e+0
Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells.
J Biol Chem. 2013 Nov 29;288(48):34343-51. doi: 10.1074/jbc.M113.480822. Epub 2013 Oct 16.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
5.5e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
5.5e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
3.8e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
3.8e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
9.7e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
9.7e-3
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
9.3e-4
9.3e-4
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
9.3e-4
9.3e-4
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
1.1e-3
1.1e-3
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
1.1e-3
1.1e-3
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
6.6e-9
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
6.6e-9
0.0e+0
Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
0.0e+0
4.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000054_1
26
/
0
/
26
mmu-miR-216b-5p
MIMAT0003729
0.0e+0
5.0e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000054_1
26
/
0
/
26
tgu-miR-216b-5p
MIMAT0014593
0.0e+0
2.9e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000054_1
26
/
0
/
26
mmu-miR-216b-5p
MIMAT0003729
0.0e+0
2.1e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000054_1
26
/
0
/
26
dpu-miR-283
MIMAT0012644
0.0e+0
4.2e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000054_1
26
/
0
/
26
mmu-miR-216b-5p
MIMAT0003729
0.0e+0
4.9e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000054_1
26
/
0
/
26
dpu-miR-283
MIMAT0012644
0.0e+0
2.7e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
0.0e+0
1.3e-1
Breast Cancer-Specific miR Signature Unique to Extracellular Vesicles includes microRNA-like tRNA Fragments.
Mol Cancer Res. 2015 Feb 26. pii: molcanres.0533.2014.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
4.6e-5
3.8e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
8.2e-5
4.0e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
4.6e-5
0.0e+0
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216a-5p
MIMAT0000273
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000054_1
26
/
0
/
26
hsa-miR-216b-5p
MIMAT0004959
1.8e-2
1.8e-2
Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.
MIPF0000054_1
26
/
0
/
26
[1]